All Articles
6 ARTICLES TAGGED "DRUG DISCOVERY"
The AI-Native Shift: Solving the Data Bottleneck in Legal & Pharma in 2024
The AI-native transformation marks a critical shift from simple data generation to the rigorous validation of insights. Explore how this evolution is reshaping legal practice, drug discovery, and the funding landscape for 10x Science.
Claude Drug Discovery: Anthropic's Superintelligence Targets Rare Diseases in 2026
Anthropic is leveraging Claude’s superintelligence to tackle the complex challenges of rare disease drug discovery. By 2026, this AI-driven approach aims to reduce costs and accelerate life-saving treatments for patients worldwide.
GPT-5.4 and the Rise of Autonomous AI Chemists: A New Era for Drug Discovery in 2026
GPT-5.4 is transforming drug discovery from a decade-long marathon into a rapid sprint. By integrating OpenAI’s latest model with advanced chemistry labs, autonomous AI chemists are now capable of developing life-saving medicines in just weeks.
GPT-Rosalind Biology AI: Revolutionizing Life Sciences and Chemistry in 2026
Explore GPT-Rosalind, OpenAI's specialized AI poised to transform life sciences and chemistry. This AI is set to accelerate breakthroughs in drug discovery and genomics.
GPT-Rosalind vs GPT-5.4-Cyber: OpenAI's Specialized Frontier AI Models of 2026
OpenAI has introduced GPT-Rosalind for specialized research in drug discovery and genomics, alongside GPT-5.4-Cyber, a model dedicated to strengthening global cybersecurity infrastructure through API grants and trusted access.
Anthropic Expands into Biotech with $400M Acquisition of Coefficient Bio
Anthropic has acquired stealth biotech startup Coefficient Bio, integrating a team of former Genentech researchers to accelerate AI applications in healthcare and life sciences. This move signals a major pivot toward specialized vertical AI in the medical field.